PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 351 (xsd:integer)
nif:isString
  • Some recent publications have shown that previous treatment with anti-PD1 drugs is associated with the early onset and the severity of vemurafenib-induced skin disorders, including hypersensitivity syndrome.13-15 Our patient started anti-BRAF therapy only 10 days after the last administration of nivolumab, without a sufficiently long washout period.
rdf:type